MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, FDMT has $512,905K in assets. $61,069K in debts. $72,488K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
933.93%
Quick Ratio
933.93%
Cash Ratio
167.01%
Debt to Asset Ratio
11.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Marketable securities, long-term
    • Less accumulated depreciation an...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease liabilities, lon...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
72,488 60,241 48,555 77,159
Marketable securities
318,404 342,414 256,508 216,066
Prepaid expenses and other current assets
14,472 10,479 7,314 10,062
Total current assets
405,364 413,134 312,377 303,287
Marketable securities, long-term
66,739 111,379 67,165 123,806
Total property and equipment
36,136 36,146 36,216 -
Less accumulated depreciation and amortization
22,549 21,279 20,063 -
Property and equipment, net
13,587 14,867 16,153 17,505
Operating lease right-of-use assets, net
17,357 18,143 18,907 19,649
Other assets
9,858 9,188 9,380 9,390
Total assets
512,905 566,711 423,982 473,637
Accounts payable
14,692 11,159 6,863 8,700
Accrued and other current liabilities
22,866 26,874 24,189 19,190
Deferred revenue
360 360 360 1,066
Operating lease liabilities, current portion
5,486 5,592 5,695 5,721
Total current liabilities
43,404 43,985 37,107 34,677
Deferred revenue, net of current portion
2,125 745 835 219
Derivative liability
370 358 345 334
Operating lease liabilities, long-term portion
15,049 15,821 16,568 17,356
Other liabilities
121 138 144 161
Total liabilities
61,069 61,047 54,999 52,747
Common stock, 0.0001 par value, 300,000,000 shares authorized at march 31, 2026 and december 31, 2025 52,271,648 and 57,607,874 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
5 6 5 5
Additional paid-in-capital
1,237,075 1,221,235 1,104,008 1,099,373
Accumulated other comprehensive gain (loss)
-180 727 671 337
Accumulated deficit
-785,064 -716,304 -735,701 -678,825
Total stockholders equity
451,836 505,664 368,983 420,890
Total liabilities and stockholders equity
512,905 566,711 423,982 473,637
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$318,404K Cash and cashequivalents$72,488K Prepaid expenses andother current assets$14,472K Total property andequipment$36,136K Total current assets$405,364K Marketable securities,long-term$66,739K Operating leaseright-of-use assets, net$17,357K Property and equipment,net$13,587K Other assets$9,858K Less accumulateddepreciation and...$22,549K Total assets$512,905K Total liabilities andstockholders equity$512,905K Total stockholdersequity$451,836K Total liabilities$61,069K Accumulated deficit-$785,064K Accumulated othercomprehensive gain (loss)-$180K Additionalpaid-in-capital$1,237,075K Total currentliabilities$43,404K Operating leaseliabilities, long-term...$15,049K Deferred revenue, net ofcurrent portion$2,125K Derivative liability$370K Other liabilities$121K Common stock, 0.0001par value,...$5K Accrued and othercurrent liabilities$22,866K Accounts payable$14,692K Operating leaseliabilities, current portion$5,486K Deferred revenue$360K

4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics, Inc. (FDMT)